Prostate Specific Antigen - PSA (Free)

For total PSA, common age-related reference ranges are: 40–49: <2.5 ng/mL; 50–59: <3.5 ng/mL; 60–69: <4.5 ng/mL; 70–79: <6.5 ng/mL. For free PSA, clinicians use the free/total PSA ratio: >25% suggests benign disease, 10–25% is indeterminate, and <10% is more suspicious for cancer. Discuss abnormal results with your doctor.

“PSA free” indicates the portion of prostate-specific antigen circulating unattached to blood proteins (free PSA). Laboratories report free PSA with total PSA; the free-to-total PSA ratio helps distinguish benign prostate conditions (higher ratio) from prostate cancer (lower ratio). It’s interpreted alongside other tests and clinical findings, so a clinician should assess results.

A higher free PSA percentage is generally better: more free (unbound) PSA relative to total PSA tends to indicate benign prostate conditions, while a low free/total PSA ratio raises the likelihood of prostate cancer. Clinically, low percentages (e.g., under ~10–15%) prompt further evaluation, whereas higher percentages (over ~25%) lower cancer probability. Discuss results with your doctor for appropriate follow-up.

Neither test alone is definitively more reliable; total PSA is the primary screening measure, while the free-to-total PSA ratio improves specificity when total PSA is borderline. A low percent free PSA suggests higher cancer risk and may prompt biopsy consideration; a higher percent suggests benign causes. Both are influenced by age, prostate size, inflammation, and medications, so results are interpreted with clinical context.

For a 70‑year‑old, many age‑adjusted references consider a PSA up to about 4–6.5 ng/mL acceptable (age‑specific upper limit often cited ≈6.5 ng/mL for 70–79). Thresholds vary and interpretation depends on trends, symptoms, free/total PSA and life expectancy. Any raised or rising PSA should be discussed with a clinician to determine repeat testing, imaging or specialist referral.

Yes — the percentage of free PSA generally declines with age while total PSA tends to rise. Older men often have a lower free-to-total PSA ratio, which can complicate interpretation because benign enlargement, inflammation, and cancer also affect levels. Clinicians use age-adjusted PSA ranges and additional tests to interpret free PSA rather than relying on a single value.